Stereotactic Body Radiation Therapy (SBRT) for a Patient with a Myocardial Metastasis: A Case Report

Curr Oncol. 2021 Jan 12;28(1):390-395. doi: 10.3390/curroncol28010041.

Abstract

Metastatic lesions of the heart are rare but have the potential to cause significant morbidity. We describe the case of a patient with renal cell carcinoma who presented with shortness of breath and palpitations and was found to have a metastatic myocardial lesion causing arrythmia. He received stereotactic body radiation therapy (SBRT) to alleviate symptoms and provide local control. SBRT planning was executed using a four-dimensional computed tomography (4DCT) scan to account for respiratory and cardiac motion. Images from a planning magnetic resonance imaging (MRI) scan and a gated diagnostic MRI scan of the heart were fused with the 4DCT to assist with delineating the tumour. A dose of 30 Gy in five fractions was delivered without incident. The patient's cardiac MRI at two months post-treatment showed stability of his cardiac lesion. He subsequently died of distant disease progression, without any recurrence of his cardiac symptoms. SBRT may be considered for patients who present with a symptomatic metastatic cardiac lesion.

Keywords: cardiac magnetic resonance imaging; myocardial metastasis; stereotactic body radiation therapy (SBRT).

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Renal Cell*
  • Humans
  • Kidney Neoplasms*
  • Magnetic Resonance Imaging
  • Male
  • Neoplasm Recurrence, Local
  • Radiosurgery*